BetterLife Pharma delays annual shareholder meeting to Dec. 9
Bitget2026/09/29 22:00- BetterLife Pharma delayed its annual shareholder meeting to Dec. 9, 2026 from Oct. 14, 2026.
- Meeting reclassified as an annual general and special meeting to add shareholder votes tied to Nasdaq listing requirements.
- Record date reset to Oct. 26, 2026; updated proxy materials targeted for distribution around Nov. 9, 2026.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Secured an order for 100,000 drone batteries, Enovix (ENVX.US) surged more than 17% after hours.
Enovix surged over 17% in after-hours trading on Tuesday after the company announced it had received an initial order of 100,000 batteries from an unnamed multinational drone system supplier.

Financial Report Soared 322% but Shares Fell Nearly 4%: Technical Death Cross Suppresses APLD (APLD.US)
App’s Q1 revenue reached $300 millions, surpassing expectations. However, due to weakness in tech stocks and a technical death cross, the stock price fell by 3.78%. Analysts maintain a buy rating and are closely watching whether the key support level at $19.5 can hold.

Getty bankruptcy privatization: AI impact collapses a 5 billion empire
Getty Images has filed for bankruptcy due to the impact of AI and a debt crisis, with its stock price plummeting by 99.95%. The family and Koch Equity have injected $533 millions for privatization, aiming to transition toward AI training authorization.
Storage stocks suffer growing pains from a narrative shift! Roundhill suggests a "barbell strategy": large-cap growth plus "halo stocks"
Drew Pettit, Chief Investment Strategist at Roundhill Investments, stated that the market does not favor stocks with a transitional narrative, and currently, storage stocks are in such an awkward position.
